Andrew Dudum - 03 Feb 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
03 Feb 2025
Net transactions value
-$3,479,057
Form type
4
Filing time
05 Feb 2025, 16:31:24 UTC
Previous filing
04 Feb 2025
Next filing
20 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise +3,159 +11% 31,077 03 Feb 2025 Direct F1
transaction HIMS Class A Common Stock Options Exercise +158,769 +511% 189,846 03 Feb 2025 Direct F1
transaction HIMS Class A Common Stock Tax liability $3,479,057 -89,367 -47% $38.93 100,479 03 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Restricted Stock Unit Options Exercise $0 -3,159 -100% $0.000000 0 03 Feb 2025 Class A Common Stock 3,159 Direct F1, F2
transaction HIMS Restricted Stock Unit Options Exercise $0 -158,769 -100% $0.000000 0 03 Feb 2025 Class A Common Stock 158,769 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units ("RSUs") represent a contingent right to to receive one share of Class A Common Stock for each RSU.
F2 In connection with the Company's business combination transaction effected in January 2021, the Reporting Person was granted RSUs that fully vest when either (i) the issuer is acquired and the per share consideration is equal to at least $38.31 per share (subject to appropriate adjustment for stock splits and otherwise, the "Threshold Amount") or (ii) the per share closing trading price of the issuer's Class A Common Stock is at least equal to the Threshold Amount (the date on which such closing trading price is achieved, the "Achievement Date"), provided that the Reporting Person remains in continuous service as chief executive officer or a director through such acquisition or the Achievement Date, as applicable.